Skip to content

The Effect of Spiritual Care on Life Expectancy and Death Anxiety in Hemodialysis patients.

The effect of the spiritual care on life expectancy and death anxiety in patients with end-stage chronic kidney disease under hemodialysis

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016030826961N1
Enrollment
Unknown
Registered
2016-05-22
Start date
2016-07-05
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End stage kidney disease. Chronic kidney disease, stage 5

Interventions

Intervention 1: The case group: (1): The case group will receive spiritual care besides the routine treatments. The patients in the case and control group will complete a demographic information ques
Lifestyle
The case group: (1): The case group will receive spiritual care besides the routine treatments. The patients in the case and control group will complete a demographic information questionnaire befor
The control group (Group 2): This group will receive the routine medical and nursing care. Contains Hemodynamic monitoring During Hemodialysis? Correct hemodialysis and Control complications of hemod

Sponsors

Vice chancellor for research of Hamadan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria of the study: 1. end-stage chronic renal failure confirmed by the physician, 2. knowing the diagnosis and prognosis of their disease, 3. hemodialysis at least for 6 months, 4. having physical and mental capability of answering the questions, 5. not knowing the mental disorders diagnosed by the physician, and 6. having minimum ability of reading and writing. Exclusion criteria of the study: 1. incidence of any stressful event for patients once the study has begun, 2. unwillingness to continue the study for any reason, and 3. hospitalization because of the disease relapse.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Death Anxiety. Timepoint: Before and one month after the start of the study. Method of measurement: Templer Death Anxiety Questionnaire.;Life Expectancy. Timepoint: Before and one month after the start of the study. Method of measurement: Life Expectancy Schneider Questionnaire.

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026